Dianthus Therapeutics (DNTH) Total Liabilities (2017 - 2025)
Dianthus Therapeutics (DNTH) posted quarterly Total Liabilities of $37.5 million for Q4 2025, up 74.27% year-over-year from $21.5 million in Q4 2024, and up 21.07% quarter-over-quarter from $31.0 million in Q3 2025.
Dianthus Therapeutics (DNTH) Total Liabilities (2017 - 2025) Analysis & Trends
Dianthus Therapeutics' Total Liabilities history runs 9 years deep, the most recent figure standing at $37.5 million for Q4 2025.
- In Q4 2025, Total Liabilities rose 74.27% year-over-year to $37.5 million; the TTM figure through Dec 2025 stood at $37.5 million (up 74.27% YoY), while the FY2025 annual figure was $37.5 million, up 74.27% from the prior year.
- Total Liabilities for Q4 2025 stood at $37.5 million, up from $31.0 million in the prior quarter.
- The five-year high for Total Liabilities was $43.2 million in Q1 2022, with the low at $4.0 million in Q2 2023.
- The 5-year median for Total Liabilities is $16.9 million (2021), against an average of $20.2 million.
- The sharpest annual moves came in 2022 and 2023: Total Liabilities surged 177.6% in 2022, then plunged 89.77% in 2023.
- Dianthus Therapeutics' Total Liabilities stood at $17.3 million in 2021, then plunged by 45.23% to $9.5 million in 2022, then gained by 11.43% to $10.5 million in 2023, then soared by 104.38% to $21.5 million in 2024, then jumped by 74.27% to $37.5 million in 2025.
- Business Quant data shows DNTH's Total Liabilities at $37.5 million in Q4 2025, $31.0 million in Q3 2025, and $23.0 million in Q2 2025.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Total Liabilities (Qtr) |
|---|---|---|---|---|---|
| 1 | Vertex Pharmaceuticals | 128.13 Bn | 120.28 Bn | 2.84 Bn | 7.18 Bn |
| 2 | Regeneron Pharmaceuticals | 112.33 Bn | 104.33 Bn | 3.93 Bn | 10.02 Bn |
| 3 | Argenx Se | 53.24 Bn | 48.05 Bn | 1.41 Bn | 1.62 Bn |
| 4 | Revolution Medicines | 43.64 Bn | 43.64 Bn | - | 1.72 Bn |
| 5 | BeOne Medicines | 39.27 Bn | 34.17 Bn | 1.53 Bn | 4.00 Bn |
| 6 | MindWalk Holdings | 35.32 Bn | 35.31 Bn | 1.82 Bn | 7.02 Mn |
| 7 | Royalty Pharma | 33.72 Bn | 35.84 Bn | - | 10.03 Bn |
| 8 | Alnylam Pharmaceuticals | 30.58 Bn | 27.27 Bn | 992.69 Mn | 4.20 Bn |
| 9 | Insmed | 27.01 Bn | 25.85 Bn | 358.27 Mn | 1.35 Bn |
| 10 | Dianthus Therapeutics | 4.97 Bn | 4.57 Bn | - | 37.52 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Dec 31, 2025 | 37.52 Mn |
| Sep 30, 2025 | 30.99 Mn |
| Jun 30, 2025 | 23.00 Mn |
| Mar 31, 2025 | 19.97 Mn |
| Dec 31, 2024 | 21.53 Mn |
| Sep 30, 2024 | 16.35 Mn |
| Jun 30, 2024 | 10.74 Mn |
| Mar 31, 2024 | 9.78 Mn |
| Dec 31, 2023 | 10.54 Mn |
| Sep 30, 2023 | 14.08 Mn |
| Jun 30, 2023 | 4.03 Mn |
| Mar 31, 2023 | 5.98 Mn |
| Dec 31, 2022 | 9.45 Mn |
| Sep 30, 2022 | 40.10 Mn |
| Jun 30, 2022 | 39.44 Mn |
| Mar 31, 2022 | 43.20 Mn |
| Dec 31, 2021 | 17.26 Mn |
| Sep 30, 2021 | 16.55 Mn |
| Jun 30, 2021 | 17.49 Mn |
| Mar 31, 2021 | 15.56 Mn |